Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Targeted proteins for diagnostic imaging: does chemistry make a difference?

A R Fritzberg, P L Beaumier

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine

|March 1, 1992

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity.

Proceedings of the National Academy of Sciences of the United States of America·2000

Same author

Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2000

Same author

Antibody pretargeted radiotherapy: a new approach and a second chance.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1998

Same author

Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate).

Bioconjugate chemistry·1998

Same author

The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases.

Nuclear medicine and biology·1997

Same author

Biorecognition of antibodies in vivo: potential in drug targeting.

Journal of molecular recognition : JMR·1996

Same journal

Overall Survival with [<sup>177</sup>Lu]Lu-PSMA-617 Versus [<sup>177</sup>Lu]Lu-PSMA I&T: A Propensity Score-Matched Real-World Analysis.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same journal

Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined <sup>18</sup>F-Flotufolastat PSMA PET and mpMRI.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same journal

PSMA PET/CT-Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same journal

Erratum.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same journal

Live from 2026 SNMMI Annual Meeting in Los Angeles!

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same journal

CAR T-Cell Therapy for Cancer: Updates and Challenges for Response Assessment.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

See all related articles

Radiolabeled protein uptake in infections depends more on the radiolabel's chemistry than the protein itself. Optimizing radiolabeling attachment and chemistry is crucial for effective diagnostic imaging.

Area of Science:

Nuclear Medicine
Radiopharmaceutical Chemistry
Molecular Imaging

Background:

Systematic evaluation of factors influencing radiolabeled protein uptake and retention in infectious foci.
Investigated the role of protein-specific interactions versus radiolabel characteristics.

Discussion:

Protein-receptor interactions appear less significant than radiolabel chemistry in determining uptake and retention.
Significant differences observed based on radionuclide type and associated chemical linkages.
Highlights the need for optimizing chemical modifications for protein carrier labeling.

Key Insights:

Radiolabel chemistry is a critical determinant of radiolabeled protein performance in infectious imaging.
Optimizing attachment and labeling chemistry is essential for improving diagnostic efficacy.

Related Experiment Videos

Evaluation criteria should include serum stability, molar substitution ratio, and blood clearance.

Outlook:

Future research should focus on characterizing radioactive metabolites and designing ligands to control their disposition.
Exploration of intracellular radiolabel processing, compartmental distribution, and internalization strategies is needed.
Development of improved chemical moieties for specific radionuclides (e.g., 111In, 99mTc) to control radiolabel fate.